<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- Vargas Llosa continued to write during his hospitalization for covid May 22, 2022
- The XXXVI Assembly of Ucoerm pays tribute to the teaching work in the pandemic Jun 29, 2021
- Celebrities struggling with bipolar disorder May 28, 2022
- Over 190,000 not vaccinated against Covid in the Balearics Sep 22, 2021
- “Intermittent Fasting” Diet: 5 Expert Tips to Manage It Properly | Video Jun 3, 2021
- Attention to the return of fake news on the ticks Jun 30, 2020
- Again the Delta variant of Covid-19 hits the weight – Explica .co Jun 30, 2021